FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 49 filers reported holding FENNEC PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $770,000 | +99.0% | 129,646 | +117.0% | 0.11% | +881.8% |
| Q4 2019 | $387,000 | -2.8% | 59,746 | -27.8% | 0.01% | +10.0% |
| Q3 2019 | $398,000 | +32.2% | 82,749 | +10.0% | 0.01% | +66.7% |
| Q2 2019 | $301,000 | -26.8% | 75,236 | -11.2% | 0.01% | -33.3% |
| Q1 2019 | $411,000 | +346.7% | 84,750 | +490.2% | 0.01% | +350.0% |
| Q4 2018 | $92,000 | – | 14,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |